Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis

Keyphrases

• Cell-based 100%
• Experimental Autoimmune Myasthenia Gravis 100%
• Regulatory T (Treg) Cells 100%
• Regulatory T 100%
• Myasthenia Gravis 28%
• Experimental Autoimmune 28%
• Treg 28%
• Healthy Donors 14%
• Myasthenic 14%
• Myasthenia 14%
• Interleukin-6 14%
• Sick 14%
• T Helper 17 (Th17) 14%
• Treatment Modalities 14%
• Anti-IL-6 14%
• Pathogenic Th17 Cells 14%
• Cell-derived 14%
• Immunopathology 14%
• Immunotherapeutic Approaches 14%
• Cell Balancing 14%

Immunology and Microbiology

• Immunotherapy 100%
• Experimental Autoimmune Myasthenia Gravis 100%
• Regulatory T Cell 100%
• Myasthenia gravis 20%
• Interleukin 6 20%
• Immunopathology 10%
• Th17 Cell 10%
• Immunology 10%